← Back to Search

Behavioral Intervention

HOP Program for Mental Illness

N/A

Recruiting

Led By Nicolas Rüsch, Dr.

Research Sponsored by University of Ulm

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

At least a moderate level of self-reported disclosure-related distress/difficulty (score 4 or higher on the screening item 'In general, how distressed or worried are you in terms of secrecy or disclosure of your mental illness to others?', rated from 1, not at all, to 7, very much)

Age 18 or above

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3, 6 and 12 weeks (t3)

Awards & highlights

No Placebo-Only Group

Summary

This trial will test a new group intervention for soldiers with mental illness to see if it is effective.

Who is the study for?

This trial is for soldiers and first responders in Berlin, Germany who are fluent in German, aged 18 or above, currently receiving mental health treatment, and experiencing distress about disclosing their mental illness. They must have a diagnosed mental disorder but not solely substance-related disorders.

What is being tested?

The 'Honest, Open, Proud' program is being tested to see if it helps soldiers with mental illnesses feel better about discussing their condition. It's a group-based intervention designed to reduce the discomfort associated with talking about one's own mental health issues.

What are the potential side effects?

Since 'Honest, Open, Proud' is a psychological support program rather than a medication or medical procedure, traditional side effects are not applicable. However, participants may experience emotional discomfort or increased anxiety when confronting issues related to their illness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I feel moderately to very distressed about sharing my mental illness with others.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3, 6 and 12 weeks (t3)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3, 6 and 12 weeks (t3)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6 and 12 weeks (t3) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Stigma Stress Scale, 8 items

WHOQoL BREF; Domain psychological quality of life, 6 items

Secondary study objectives

Attitudes to disclosure, 2 items

Attitudes to help-seeking, 2 items

Disclosure related distress ("In general, how distressed or worried are you in terms of secrecy or disclosure of your mental illness to others?', from 1, not at all, to 7, very much)

+8 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Honest, Open, ProudExperimental Treatment1 Intervention

The group program is about disclosure versus secrecy of one's mental illness. The groups are facilitated by two peers (soldiers with lived experience of mental illness). Each group runs for three weeks, one meeting per week, and two hours per meeting. There is one 2-hour booster session in week 6. Fidelity to manual: rated by a research assistant who is present during the group session

Group II: Control groupActive Control1 Intervention

Treatment as usual (TAU)

0 / 2Eligibility criteria met